Alpa Laboratories Ltd (ALPA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 476646,
    "name": "Alpa Laboratorie",
    "stock_name": "Alpa Laboratorie",
    "full_name": "Alpa Laboratories Ltd",
    "name_url": "stocks-analysis/alpa-laboratorie",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "67.89",
    "chg": -0.66,
    "chgp": "-0.96%",
    "dir": -1,
    "prev_price": "68.55",
    "mcapval": "142.84 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532878,
    "symbol": "ALPA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE385I01010",
    "curr_date": "Jul 21, 09:33 AM",
    "curr_time": "09:50 AM",
    "last_traded_at": "Jul 21, 09:33 AM IST",
    "bse_nse_vol": "986 ",
    "exc_status": "Active",
    "traded_date": "Jul 21, 2026",
    "traded_date_str": "2026 07 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alpa-laboratorie-476646-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4108036",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlpaLaboratorie_mojoScore_4108036.png",
        "date": "2026-07-19 10:10:03",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 July 2026, providing investors with an up-to-date perspective on its performance and outlook."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4092284",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlpaLaboratorie_mojoScore_4092284.png",
        "date": "2026-07-07 10:10:03",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4074070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlpaLaboratorie_mojoScore_4074070.png",
        "date": "2026-06-26 10:10:03",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4054246",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlpaLaboratorie_mojoScore_4054246.png",
        "date": "2026-06-15 10:10:04",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Alpa Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alpa-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4029215",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlpaLaboratorie_valuationdot_4029215.png",
        "date": "2026-06-02 08:02:11",
        "description": "Alpa Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade. This change, coupled with its current price-to-earnings (P/E) ratio of 9.85 and price-to-book value (P/BV) of 0.79, positions the stock as a potentially undervalued opportunity relative to its historical averages and peer group."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4026072",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlpaLaboratorie_mojoScore_4026072.png",
        "date": "2026-06-01 10:10:35",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Alpa Laboratories Q4 FY26: Profit Recovery Masks Deeper Revenue Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/alpa-laboratories-q4-fy26-profit-recovery-masks-deeper-revenue-concerns-4024038",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlpaLaboratorie_quaterlyResult_4024038.png",
        "date": "2026-05-30 20:18:37",
        "description": "Alpa Laboratories Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹148.00 crores, reported a net profit of ₹1.38 crores for Q4 FY26, marking a sharp recovery from the previous year's loss of ₹2.12 crores. However, the positive earnings reversal conceals troubling revenue trends, as net sales declined 21.34% year-on-year to ₹31.40 crores, raising questions about the sustainability of the company's business momentum in an otherwise buoyant pharmaceutical sector."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4000845",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlpaLaboratorie_mojoScore_4000845.png",
        "date": "2026-05-20 10:10:21",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 20 May 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-3982883",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlpaLaboratorie_mojoScore_3982883.png",
        "date": "2026-05-09 10:10:14",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 120,
    "sid": "476646",
    "stock_news_url": "https://www.marketsmojo.com/news/alpa-laboratories-476646"
  },
  "announcements": [
    {
      "details": "Alpa Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 23(9) of SEBI (LODR) 2015 for the period ended 30th September, 2019.'.",
      "source": "NSE",
      "caption": "Alpa Laboratories Limited - Updates",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Alpa Laboratories Limiteds Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Alpa Laboratories Limited - Clarification - Financial Results",
      "datetime": "14-Nov-2019"
    },
    {
      "details": " <table><tr><td>The Exchange had sought clarification from Alpa Laboratories Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. </td></tr></table>",
      "source": "NSE",
      "caption": "Reply to Clarification- Financial results",
      "datetime": "12-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alpa Laboratories Ltd is Rated Sell

2026-07-19 10:10:03

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 July 2026, providing investors with an up-to-date perspective on its performance and outlook.

Read full news article

Alpa Laboratories Ltd is Rated Sell

2026-07-07 10:10:03

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Alpa Laboratories Ltd is Rated Sell

2026-06-26 10:10:03

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Alpa Laboratories Ltd is Rated Sell

2026-06-15 10:10:04

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Alpa Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-02 08:02:11

Alpa Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade. This change, coupled with its current price-to-earnings (P/E) ratio of 9.85 and price-to-book value (P/BV) of 0.79, positions the stock as a potentially undervalued opportunity relative to its historical averages and peer group.

Read full news article

Alpa Laboratories Ltd is Rated Sell

2026-06-01 10:10:35

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Alpa Laboratories Q4 FY26: Profit Recovery Masks Deeper Revenue Concerns

2026-05-30 20:18:37

Alpa Laboratories Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹148.00 crores, reported a net profit of ₹1.38 crores for Q4 FY26, marking a sharp recovery from the previous year's loss of ₹2.12 crores. However, the positive earnings reversal conceals troubling revenue trends, as net sales declined 21.34% year-on-year to ₹31.40 crores, raising questions about the sustainability of the company's business momentum in an otherwise buoyant pharmaceutical sector.

Read full news article

Alpa Laboratories Ltd is Rated Strong Sell

2026-05-20 10:10:21

Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 20 May 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Alpa Laboratories Ltd is Rated Strong Sell

2026-05-09 10:10:14

Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News